Edition:
United States

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,738.05INR
5:15am EST
Change (% chg)

Rs-1.40 (-0.05%)
Prev Close
Rs2,739.45
Open
Rs2,725.00
Day's High
Rs2,774.40
Day's Low
Rs2,725.00
Volume
5,957
Avg. Vol
17,629
52-wk High
Rs3,872.00
52-wk Low
Rs2,600.00

Summary

Name Age Since Current Position

Deepak Parekh

72 Non-Executive Chairman of the Board

Andrew Aristidou

2014 Chief Financial Officer, Executive Director

D. Bartaria

2015 Executive Vice President– Pharmaceuticals

H. Buch

2012 Executive Vice President - Pharmaceuticals

Ajay Nadkarni

2011 Compliance Officer, Company Secretary, General Manager - Administration

S. Khanna

Vice President - Finance

Annaswamy Vaidheesh

2015 Managing Director, Vice President, South Asia

S. Dheri

2012 Vice President - Biologicals

K. Hazari

2011 Vice President - Legal & Corporate Affairs

V. Desai

2013 General Manager - Medical & Clinical Research

Ronald Sequeira

2007 Executive Director - Human Resources, Director

Raju Krishnaswamy

2016 Whole- time Director

Regis Simard

2015 Non-Executive Director

R. Bajaaj

2002 Non-Executive Independent Director

Anjali Bansal

2013 Non-Executive Independent Director

Pradeep Bhide

66 2010 Non-Executive Independent Director

Nihal Vijaya Devadas Kaviratne

72 2005 Non-Executive Independent Director

Anami Roy

62 2011 Non-Executive Independent Director

D. Sundaram

61 2009 Non-Executive Independent Director

Biographies

Name Description

Deepak Parekh

Mr. Deepak S. Parekh is Non-Executive Chairman of the Board of GlaxoSmithKline Pharmaceuticals Ltd. He is a Chairman of Investors / Shareholders Grievance Committee, Member of Audit Committee.

Andrew Aristidou

Mr. Andrew Aristidou is the Chief Financial Officer, Executive Director of the GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. Andrew has a B.Sc. (Hons.) in Economics and Accountancy from Loughborough University in the United Kingdom. He is also a Fellowship Chartered Accountant of the ICAEW (Institute of Chartered Accountants in England and Wales) having qualified with Price Waterhouse in London. Andrew has most recently been Head of Corporate Development, Europe and International Finance for ViiV Healthcare in London. He first joined GlaxoSmithKline in 1999 holding a number of roles of increasing importance including North Andes Finance Director based in Venezuela, as well as Corporate Development Director and Southern & Eastern European Finance Director. In 2007 he joined Gilead Sciences as International Director of Financial Planning and Analysis before rejoining the GlaxoSmithKline Group in 2010 into the ViiV Healthcare organization. Andrew is appointed as Executive Director and Chief Financial Officer of the Company from 1st December 2014. He is a Director of Biddle Sawyer Limited which forms part of the GlaxoSmithKline Group Companies in India. He does not hold any shares of the Company.

D. Bartaria

Mr. D. Bartaria is the Executive Vice President– Pharmaceuticals of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED.

H. Buch

Mr. H. Buch is an Executive Vice President - Pharmaceuticals of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED.

Ajay Nadkarni

Mr. Ajay A. Nadkarni is Compliance Officer, Company Secretary, General Manager - Administration of GlaxoSmithKline Pharmaceuticals Ltd.

S. Khanna

Mr. S. Khanna is Vice President - Finance of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED.

Annaswamy Vaidheesh

Mr. Annaswamy Vaidheesh is the Managing Director, Vice President, South Asia of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED.

S. Dheri

Mr. S. Dheri is Vice President - Biologicals of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED., since April 1, 2012.

K. Hazari

Mr. K. Hazari is Vice President - Legal & Corporate Affairs of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED., since August 1, 2011.

V. Desai

Dr. V. Desai is the General Manager - Medical & Clinical Research of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED.

Ronald Sequeira

Mr. Ronald C. Sequeira is an Executive Director - Human Resources, Director of Glaxosmithkline Pharmaceutical Limited. Mr. Sequeira is an alumni of Loyola College, Chennai and XLRI, Jamshedpur and has 29 years of experience in the field on Human Resources with multinational companies in India. He began his HR career in 1984 as a Management Trainee with Union Carbide India Limited and gained employee relations experience in various positions. He was appointed Personnel Manager in 1990. In 1992, he moved to the HSBC Bank where he handled HR for East and West India and headed Resourcing and Development and later he was appointed HR Manager Asia Pacific, based in Hong Kong. Mr. Sequeira has also held the position of Head of Compensation and Employee Relations with HSBC, India. Mr. Sequeira joined Tata Power Company in 2004 as VP and Head of Human Resources with additional charge for the Company’s Corporate Social Responsibility function. He was also on the Tata Group’s HR steering Committee. He has been in the service of the Company since 2006 and was elevated to the Board in 2007. He is a Director of Biddle Sawyer Limited which forms part of the GlaxoSmithKline Group Companies in India. He is also a Director in Hill Properties Limited.

Raju Krishnaswamy

Mr. Raju Krishnaswamy is an Executive Director - Technical, Director of GlaxoSmithKline Pharmaceuticals Ltd. Mr. Krishnaswamy has completed his B. Pharm from JSS college of Pharmacy Ooty and has undertaken Ex.MBA from ICFAI. Prior to joining the Company, Mr. Krishnaswamy worked as Senior Vice - President, Global Manufacturing with Wockhart Limited. In this capacity, he was the manufacturing operations of Wockhart in India, U.S.A and Ireland. He headed the contract manufacturing services and the R&D formulation for India and rest of the world countries. Earlier, Mr. Krishnaswamy has had stints with organisations like Cipla Limited, Bangalore and Ranbaxy Laboratories Limited. He was working on the Boards of Wockhart Infrastructure Development Limited and Wockhart Biopharm Limited.

Regis Simard

Mr. Regis Simard is the Non-Executive Director of GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. Mr. Regis Simard is a Mechanical Engineer and also holds an MBA. He has held senior management positions in the Electronic and Tech industries (Sony, Konica-Minolta) and in the Healthcare and Medical devices industries (Covidien) where he gained valuable experience working with Japan, China, UK and France. Regis joined GlaxoSmithKline in 2005 as Site Director at the GSK France plant at Notre Dame de Bondeville, then moved to GSK House UK to lead the Antibiotics and Latina Manufacturing cluster. In January 2011, Regis was appointed Commercial Partner Emerging Markets & Asia Pacific. In January 2013 Regis was appointed to his current role as Senior Vice-President/ Head of Europe and EMAP Pharma Supply. Regis is a member of both the Supply Chain Executive team and the Emerging Markets Commercial leadership team. Diverse and broad experience of manufacturing, leadership to distil complexity and convey clear strategic direction, high levels of commerciality and customer/patient focus, incisive and focused when it comes to driving delivery, strong interest in people development.

R. Bajaaj

Mr. R. R. Bajaaj is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Limited. Mr. Bajaaj is a graduate in Science and Law. He joined Mahindra & Mahindra Limited as Management Trainee in 1964. He then moved on to Otis Elevator Company (India) Limited in their Field Operations Department in 1967 and held a series of senior roles within that Company including Head of Northern Regional Operations, Country Head for Middle East and South East Asia countries. Mr. Bajaaj returned to India as Managing Director of Otis Elevator Company (India) Limited in 1989. In 2000, he was appointed as Vice- President South and South East Asia operations based in Singapore. In 2001, he took up international assignment with an NGO Special Olympics Inc. as Managing Director, Asia Pacific. In 2006, he entered into a Joint Venture with the world’s Consulting Firm for Vertical Transportation, Lerch Bates which is Head quartered in Denver, U.S.

Anjali Bansal

Ms. Anjali P. Bansal is Non-Executive Independent Director of GlaxoSmithKline Pharmaceuticals Ltd. She received a master’s degree in International Affairs, with distinction, from Columbia University in New York, where she majored in International Finance and Business, as well as a bachelor’s degree in Computer Engineering from Gujarat University. Ms. A. Bansal is Managing Director of Spencer Stuart’s Indian business, which she was instrumental in establishing. Based in Mumbai, she also co-leads the firm’s Asia Pacific Board & CEO Succession practice. As an active member of the Global Board practice, she works in various geographies across the United States, Europe and Asia, advising Indian and multinational companies on CEO and senior executive search, Board governance and succession. She also consults with clients across sectors, including private equity, financial services, technology, industrial and consumer goods and services. In addition, she chairs the board of FWWB (Friends of Women’s World Banking), a development and livelihood-promoting institution, serves on the board of the United Way of Mumbai, and is a charter member of The Indus Entrepreneurs (TiE). Ms. A. Bansal is a frequent commentator on Board governance, CEO succession, entrepreneurship and other executive leadership issues. She is a regular columnist with publications such as Mint-The Wall Street Journal and The Economic Times: Corporate Dossier. Earlier, Ms. A. Bansal was with McKinsey & Company as a strategy consultant. Based in New York and Mumbai, she consulted with firms in financial services, private equity, industrial, and technology sectors.

Pradeep Bhide

Mr. Pradeep Vasudeo Bhide is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Ltd. He is Science and Law graduate from Delhi University, has done his Master’s in Business Administration from IGNOU. He is enrolled as an Advocate with Delhi Bar Council. Mr. Bhide joined the Indian Administrative Service in 1973 and has served for 37 years. He held a series of increasingly senior positions at the State and Central levels. He worked as Secretary for Department of Finance and then Department of Energy of Andhra Pradesh. He was a Deputy Secretary / Director in the Department of Economic Affairs, Ministry of Finance and served as Advisor to India’s Executive Director to the International Board for Reconstruction and Development, Washington. Mr. Bhide then served as Additional Secretary / Special Secretary in the Ministry of Home Affairs of the Government before being appointed as Secretary in the Department of Divestment with the Ministry of Finance. Mr. P. V. Bhide retired as Secretary, Department of Revenue, Ministry of Finance in January 2010, a position which he held from June 2007. He was appointed as Non-Executive Independent Director of the Company from 28th October 2010. He is a Director of Tube Investments India Limited, L&T Finance Limited, Ballarpur Industries Limited, NOCIL Limited, Heidelberg Cement India Limited, L&T Finance Holdings Limited and BILT Graphic Paper Products Limited. He is the Chairman of the Audit Committee of L&T Finance Limited and Ballarpur Industries Limited and the member of the Audit Committee of Heidelberg Cement India Limited and Tube Investments India Limited. He is also the member of the Investors / Shareholders Grievance Committee of Heidelberg Cement India Limited.

Nihal Vijaya Devadas Kaviratne

Mr. Nihal Vijaya Devadas Kaviratne is Non-Executive Independent Director of Glaxosmithkline Pharmaceutical Limited. Mr. Nihal Kaviratne has an Honours degree in Economics from Mumbai University. He joined them in India as a Management Trainee in 1966, and held a series of senior roles including Head of Marketing Research and Economics and General Manager of Export Division. In 1984 he moved as Managing Director of the Detergents Division in Indonesia, and later became Regional Leader for Latin America and South Asia at Corporate Headquarters in London, Managing Director in Argentina and Chairman in Indonesia. He was appointed Senior Vice President - Development and Environmental Affairs, Unilever Asia, based in Singapore and Chairman of Unilever’s Home and Oral Care businesses in Asia. He was awarded the CBE for services to UK business interests and for sustainable development in Indonesia. He is a Director of Company since July 2005 and is the member of Audit Committee. Mr. Kaviratne is the Chairman of Akzo Nobel India Limited and of the Indian Cancer Society. He is President Commissioner of TVS Indonesia and a Director of several Singapore based companies including the DBS Group, SATS, StarHub and Wildlife Reserves Singapore.

Anami Roy

Mr. Anami N. Roy is Non-Executive Independent Director of GlaxoSmithKline Pharmaceuticals Ltd., since November 4, 2011. He holds a Master degree in History and is a retired civil servant. During his 38 years long career in the Indian Police Service (“IPS”), he held with great distinction a range of assignments including some of the challenging and sensitive ones, both in the Maharashtra State and Government of India. He retired in May, 2010 as the Director General of Police (DGP), Maharashtra, heading a police force of 2,00,000. As the DGP Maharashtra, he was the advisor to the State Government for internal security, law and order and crime administration. Mr. Roy, as Police Commissioner of Mumbai for over three years has many instruments and schemes for making Police services more accessible to citizens and people-friendly. Citizen Facilitation Centers for providing time-bound, transparent, hassle-free solutions to people’s expectations from the Police were appreciated by people and media. As Managing Director of Police Housing Corporation, he galvanized the work of planning, financing and executing projects of housing and office building construction for Police and other organizations under Home Department of Government of Maharashtra. As the Director General of Anti-Corruption Bureau, he initiated a policy document on Vigilance matters for Government of Maharashtra and took many steps for checking corruption in Government working. He was responsible for all operational matters in the elite Special Protection Group, charged with the responsibility of the proximate security of the Prime Minister and former Prime Ministers. He has knowledge and experience of security and Intelligence matters at the state and national level.

D. Sundaram

Mr. D. Sundaram is Non-Executive Independent Director of GlaxoSmithKline Pharmaceuticals Ltd., since July 27, 2009. He is a commerce graduate and a post graduate in Management Studies from Madras University. He is a Fellow of the Institute of Cost Accountants and has done the Advanced Management Programme at Harvard Business School. Mr. Sundaram joined Hindustan Lever (Unilever group) in India as Management Trainee in 1975 and held increasingly senior roles in HLL in Accounting, Commercial and Treasury functions at Mumbai, was Finance Officer at Unilever (London) for Africa and Middle East Region, Finance Director and Board Member of Brooke Bond Lipton India Limited and was Senior Vice-President (Finance and IT), South Asia and Middle East Group based at London. Mr. Sundaram was appointed as Finance Director and Board Member of Hindustan Lever Limited and subsequently became Vice-Chairman and CFO of the Company; he was also responsible for Pakistan, Bangladesh and Sri Lanka. Mr. Sundaram was twice awarded CFO of the year for the FMCG sector by CNBC TV 18 in 2006 and 2009; he was given the “icon of the profession’’ award by Institute of Cost Accountants. Currently he is the Vice-Chairman and Managing Director of TVS Capital Funds Limited since July 2009. He is an Independent Director on the Boards of State Bank of India, SBI Capital Market and TVS Electronics Ltd among others. He is the Chairman of the Audit Committee of SBI Capital Market and TVS Electronics Limited. He is a Member of Audit Committee and Remuneration Committee of State Bank of India.